An advisory panel has recommended that the FDA approve flibanserin, the first drug to treat a lack of sexual desire in women.  The pill works by influencing the level of certain chemicals in the brain, such as serotonin and dopamine.  The drug has previously been rejected twice by FDA and has the potential side effects of low blood pressure, nausea and dizziness.

The New York Times reports that several advisory panel members said they voted “yes” with great misgivings because of the drug’s modest benefit and possible side effects.  The Times reports:

“Three clinical trials testing flibanserin were consistent in their results.  The women who took part were having an average of two to three of what they defined as ‘sexually satisfying events’ per month when the studies began.  Once they started taking the drug the number of such events increased by only about one event per month more than for women in the trial who got a placebo.”

Rather than await the probable introduction of the flibanserin pill, woman who wish to increase their sexual desire and pleasure should consider the O-Shot®, a simple non-invasive procedure administered by Dr. ChinQuee involving the injection of a woman’s own platelet rich plasma (PRP) growth factors into a specific area of the upper wall and clitoris for the purpose of amplification of orgasm producing vagina tissue for improved sexual performance.  The effects can last up to six months to a year, but will vary.

Women who experience vaginal dryness, which can cause painful intercourse, should consider fractional C02 laser vaginal treatments by Dr. ChinQuee which stimulate the production of collagen to create healthier vaginal tissue.  The procedure is made up of three less than five minute laser sessions, each six weeks apart.  It is relatively painless and no anesthesia or painkillers are required.